Gene therapies for rare diseases: an interview with Frederic Revah, Genethon

In Orphan Drug Congress by Tim Peplow

Total Orphan Drugs sat down with Frederic Revah, CEO of Genethon, at the World Orphan Drug Congress Europe 2013 to discuss gene therapies and innovative approaches to rare disease therapies.